Figure 4

MVs collected from the plasma of tumor-bearing mice injected with propofol enhance anti-HCC in vivo . The tumor-bearing mice were treated with MVs collected from the plasma of tumor-bearing mice injected with or without propofol. (A) The level of plasma miR-142-3p was detected. (B) Tumor sizes and (C) tumor weights were measured in tumor-bearing mice injected with plasma MVs. *P < 0.05, indicate significant differences from control.